MiMo(TM) Negative Pressure Wound Therapy System— 510(k) K181929

Substantially Equivalent

Baymax Research, Inc.

FDA 510(k) clearance K181929 for MiMo(TM) Negative Pressure Wound Therapy System, Substantially Equivalent on 2019-03-27. Applicant: Baymax Research, Inc..

Clearance details

Applicant
Baymax Research, Inc.
Product code
Code OMP
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
New York, NY, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code OMP

product code OMP
Death
31
Injury
1,707
Malfunction
4,047
Other
1
Total
5,786

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.